Roquefort Therapeutics PLC (ROQ)

ORD 1P

Sell: 0.90p|Buy: 1.10p|Change: 0.04 (-4.21%)

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Company profile

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. The product portfolio of the company consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical development of next-generation medicines focused on hard-to-treat cancers.

Address

Eccleston Yards, 25 Eccleston Place
London
GBR
SW1W 9NF

Telephone

+44 2032909339

Website

https://www.roquefortplc.com

Sector

Healthcare

Forecast key dates

Name	Key Date
Roquefort Therapeutics PLC Second Quarter Earnings Results for 2026	2026-09-30T00:00:00
Roquefort Therapeutics PLC Annual General Meeting for 2025	2026-06-26T10:00:00
Roquefort Therapeutics PLC Fourth Quarter Earnings Results for 2025	2026-04-30T00:00:00
Roquefort Therapeutics PLC Annual Report for 2025	2026-04-30T00:00:00

Previous key dates

Name	Key Date
Roquefort Therapeutics PLC Second Quarter Earnings Results for 2025	2025-09-30T00:00:00
Roquefort Therapeutics PLC Annual General Meeting for 2024	2025-06-26T10:00:00
Roquefort Therapeutics PLC Fourth Quarter Earnings Results for 2024	2025-04-30T00:00:00
Roquefort Therapeutics PLC Annual Report for 2024	2025-04-30T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.